Western University

Scholarship@Western
Microbiology & Immunology Publications

Microbiology & Immunology Department

5-2015

How Probiotics and the Microbiome Will Change
Medical Practice
Gregor Reid
Lawson Health Research Institute, gregor@uwo.ca

Follow this and additional works at: https://ir.lib.uwo.ca/mnipub
Part of the Immunology and Infectious Disease Commons, and the Microbiology Commons
Citation of this paper:
Reid, Gregor, "How Probiotics and the Microbiome Will Change Medical Practice" (2015). Microbiology & Immunology Publications.
48.
https://ir.lib.uwo.ca/mnipub/48

Perspectives

How Probiotics and the Microbiome Will Change
Medical Practice
Gregor Reid, PhD, MBA, ARM, CCM, Dr. HS, FCAHS, Director of the Canadian Centre for Human Microbiome and Probiotic
Research, Lawson Health Research Institute, Professor, Departments of Microbiology and Immunology, and Surgery, The
University of Western Ontario

T

he Bell Wing at Toronto General Hospital has long
gone, but in the Fall of 1982, that was where I began
my journey into human microbiome and probiotic
research. Stimulated by mentor Dr. Andrew Bruce, Head of
Urology, I asked the question: “Were there beneficial bacteria in the urogenital tract and if they help prevent infection,
could they be replenished to reset an infectious state back to
normal?” Thirty-three years later, this is arguably the hottest
field of medicine, and one that will transform its practice for
years to come.
Humans have evolved from microbes, so it should be no
surprise to find these organisms playing a key role in health.
But, who would have thought they would be living in the
brain,1 breast tissue,2 stomach,3 in some sort of suspended
state, and, through the gut, influencing metabolism,4 cardiac health,5,6 anxiety7 and bone density,8 to name a few? Who
would have imagined being able to identify over 200 species
present in any given niche within hours using a device the
size of a Mars Bar?9 And to be able to detect disease through
metabolic by-products from these microbes?10 A mere eleven
years ago, the word probiotic was barely in the medical language, and viewed by some as snake oil: today, its market size
is around $30 billion. The transfer of feces from human donor to recipient was unimaginable not long ago, but to find
that it has a 90% cure rate of deadly Clostridium difficile infection11 and to consider doing this to prevent obesity or delay
mental illness12 would have seemed draconian just ten years
ago. Yet, here we are today recognizing that microbes play
an integral part in health and disease. Indeed, potentially in
the determinants of health and their developmental origins.
Where could the future possibly take us?
These discoveries are playing havoc with traditional practices and systems we established within our society. From
the early 20th Century, regulatory agencies were set up and
instructed to adjudicate that drugs could prevent, treat and
cure disease. Fast forward to the present, it seems absurd
to suggest that microbial-containing food and supplements
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need to be defined as drugs that must be prescribed to treat,
prevent and potentially even cure some diseases. The FDA,
for example, clearly demands that this should happen.13 Not
only that, the system of registering bacterial strains as part
of regulatory procedures does not allow for depositing strain
combinations, even though once separated from each other,
such strains die, thereby defeating the whole purpose of deposition.
The education of medical doctors and other healthcare
professionals has been streamlined in recent years, with
teaching the importance of beneficial microbes all but deleted. If our healthcare specialists don’t understand this area,
how can we ask them to manage health issues associated with
microbes, and recommend interventions and approaches
outside of drug prescriptions? Continual medical education
and conferences might help, but they often convey opinions
rather than establish guidelines and basic training. With companies creating diagnostic systems to relay microbiome and
metabolome data,10 practitioners must be able to interpret
them and consider the ethical implications of disclosing the
information.14
If the composition of the gut microbiome influences drug
adsorption,15 should all drugs not be re-tested against a patient’s microbes? The implications are enormous, but this
aspect of personalized medicine is clearly on the horizon.
Probiotics have been shown to augment the effects of some
drugs,16,17 but how do physicians write a script for a probiotic
food? The creation of Guidelines that outline probiotic products that have been at least clinically tested18 certainly helps
consumers plod through the multitude of products available,
and recognize those that have not been tested for effectiveness in humans.
As the microbiome appears to form into an ‘adult’ composition by around age three, and as many diseases are already
conditioned by then, the question of ‘programming’ the microbiome during fetal and early life must be considered. The
best way of doing this is far from understood, but manipulation of one form or another is already taking place through
the placenta,19 breast milk,20 and probiotic infant formula.21
Longitudinal studies are needed to understand this crucial
stage in life, yet Canada, the European Union and USA have
ceased funding large microbiome programs, and pay lip service to the funding of probiotic research and indeed research
on what makes people healthy. This is ironic considering the
funders are institutes of ‘health’.
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While surgery and other invasive interventions will be necessary long into the future, many other aspects of medicine
will change dramatically in the next twenty years. Interpretation of data, whether acquired in centres or by individuals, will become paramount, and a holistic understanding of
anatomy and physiology, nutrition and the microbiome will
be essential. Metchnikoff directed us to ask why Bulgarian
peasants lived so long22 and how fermented foods were associated with it. The key to a long, healthy life likely does lie
in our food and microbes - we just need to understand how
best to align them, in some cases also taking into consideration our genetic endowment. Time will tell how quickly we
embrace the future.
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